Evidence map›Paper›PMID 35728836›Full record

ArticleBMJ global health2022

Pandemic inequity in a megacity: a multilevel analysis of individual, community and healthcare vulnerability risks for COVID-19 mortality in Jakarta, Indonesia.

Henry Surendra, Ngabila Salama, Karina D Lestari, Verry Adrian, Widyastuti Widyastuti, Dwi Oktavia, Rosa N Lina, Bimandra A Djaafara, Ihsan Fadilah, Rahmat Sagara and 10 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in BMJ global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 3 countries.

Henry SurendraEijkman-Oxford Clinical Research Unit, Jakarta, Indonesia henrysurendra.15@gmail.com.ORCID 0000-0002-6029-0623
Ngabila SalamaDKI Jakarta Health Office, Jakarta, Indonesia.
Karina D LestariEijkman-Oxford Clinical Research Unit, Jakarta, Indonesia.
Verry AdrianDKI Jakarta Health Office, Jakarta, Indonesia.
Widyastuti WidyastutiDKI Jakarta Health Office, Jakarta, Indonesia.
Dwi OktaviaDKI Jakarta Health Office, Jakarta, Indonesia.
Rosa N LinaEijkman-Oxford Clinical Research Unit, Jakarta, Indonesia.
Bimandra A DjaafaraEijkman-Oxford Clinical Research Unit, Jakarta, Indonesia.ORCID 0000-0001-7481-2624
Ihsan FadilahEijkman-Oxford Clinical Research Unit, Jakarta, Indonesia.ORCID 0000-0001-9507-6427
Rahmat SagaraEijkman-Oxford Clinical Research Unit, Jakarta, Indonesia.ORCID 0000-0001-6862-1282
Lenny L EkawatiEijkman-Oxford Clinical Research Unit, Jakarta, Indonesia.
Ahmad NurhasimThe Conversation Indonesia, Jakarta, Indonesia.
Riris A AhmadCentre for Tropical Medicine, Faculty of Medicine, Public Health and Nursing, Gadjah Mada University, Yogyakarta, Indonesia.ORCID 0000-0001-9340-3922
Aria KekalihFaculty of Medicine, University of Indonesia, Jakarta, Indonesia.
Ari F SyamFaculty of Medicine, University of Indonesia, Jakarta, Indonesia.
Anuraj H ShankarEijkman-Oxford Clinical Research Unit, Jakarta, Indonesia.
Guy ThwaitesCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
J Kevin BairdEijkman-Oxford Clinical Research Unit, Jakarta, Indonesia.
Raph L HamersEijkman-Oxford Clinical Research Unit, Jakarta, Indonesia.ORCID 0000-0002-5007-7896
Iqbal R F ElyazarEijkman-Oxford Clinical Research Unit, Jakarta, Indonesia.
Eijkman Institute for Molecular Biology · IDUniversitas Gadjah Mada · IDUniversity of Indonesia · IDUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWorldwide, the 33 recognised megacities comprise approximately 7% of the global population, yet account for 20% COVID-19 deaths. The specific inequities and other factors within megacities that affect vulnerability to COVID-19 mortality remain poorly defined. We assessed individual, community-level and healthcare factors associated with COVID-19-related mortality in a megacity of Jakarta, Indonesia, during two epidemic waves spanning 2 March 2020 to 31 August 2021.

methodsThis retrospective cohort included residents of Jakarta, Indonesia, with PCR-confirmed COVID-19. We extracted demographic, clinical, outcome (recovered or died), vaccine coverage data and disease prevalence from Jakarta Health Office surveillance records, and collected subdistrict level sociodemographics data from various official sources. We used multilevel logistic regression to examine individual, community and subdistrict-level healthcare factors and their associations with COVID-19 mortality.

resultsOf 705 503 cases with a definitive outcome by 31 August 2021, 694 706 (98.5%) recovered and 10 797 (1.5%) died. The median age was 36 years (IQR 24-50), 13.2% (93 459) were <18 years and 51.6% were female. The subdistrict level accounted for 1.5% of variance in mortality (p<0.0001). Mortality ranged from 0.9 to 1.8% by subdistrict. Individual-level factors associated with death were older age, male sex, comorbidities and age <5 years during the first wave (adjusted OR (aOR)) 1.56, 95% CI 1.04 to 2.35; reference: age 20-29 years). Community-level factors associated with death were poverty (aOR for the poorer quarter 1.35, 95% CI 1.17 to 1.55; reference: wealthiest quarter) and high population density (aOR for the highest density 1.34, 95% CI 1.14 to 2.58; reference: the lowest). Healthcare factor associated with death was low vaccine coverage (aOR for the lowest coverage 1.25, 95% CI 1.13 to 1.38; reference: the highest).

conclusionIn addition to individual risk factors, living in areas with high poverty and density, and low healthcare performance further increase the vulnerability of communities to COVID-19-associated death in urban low-resource settings.

Indexed as

COVID-19PandemicsAdultChild, PreschoolDelivery of Health CareFemaleHumansIndonesiaMaleMultilevel AnalysisRetrospective StudiesYoung AdultCOVID-19epidemiologyhealth systemspublic health

Identifiers

PMID35728836
PMCPMC9213779
OpenAlexW4283331732

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.